SCHEMBL6528671

SCHEMBL6528671

Clc1cccc(C[CH]c2c[nH]cn2)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.40
HTR3E A5X5Y0 2/20 0.38
HTR3B O95264 2/20 0.38
HTR3A P46098 2/20 0.38
HTR3D Q70Z44 2/20 0.38
HTR3C Q8WXA8 2/20 0.38
ACP1 P24666 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
CDC7 O00311 4/20 0.37
DBF4 Q9UBU7 4/20 0.37
IDO1 P14902 3/20 0.37
CYP3A4 P08684 2/20 0.37
AGXT P21549 2/20 0.37
DAO P14920 1/20 0.35
BACE1 P56817 1/20 0.35
PIN1 Q13526 1/20 0.35
TMIGD3 P0DMS9 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11209147 0.85 IDO1 (0.38) PNMTHTR3EHTR3BHTR3AHTR3D
SCHEMBL6531584 0.81 MAPK1 (0.35) ACP1TAAR1CDC7DBF4IDO1
SCHEMBL1196870 0.80 MAOB (0.40) TAAR1CDC7DBF4
SCHEMBL6528481 0.78 HTR1B (0.43) TAAR1CDC7DBF4IDO1AGXT
SCHEMBL2105133 0.73 PNMT (0.43) PNMTTAAR1CDC7DBF4IDO1
SCHEMBL223834 0.72 BACE1 (0.50) PNMTHTR3EHTR3BHTR3AHTR3D
SCHEMBL6529660 0.72 KMT2A (0.39) PNMTACP1TAAR1CDC7DBF4
SCHEMBL167780 0.70 PNMT (0.56) PNMTHTR3EHTR3BHTR3AHTR3D
SCHEMBL6031658 0.70 CHRM5 (0.53) PNMTHTR3EHTR3BHTR3AHTR3D
SCHEMBL11266744 0.69 IDO1 (0.39) TAAR1IDO1DAOPIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed